RPRX
RPRX
NASDAQ · Pharmaceuticals

Royalty Pharma Plc- Cl A

Large-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks
$53.57
+0.61 (+1.15%)
As of Jun 22, 9:37 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 14 88%
Hold 2 13%
Sell 0 0%
Price Target
Analyst Price Target -32.3% upside
Low Target $26.65
Average Target $36.26
High Target $40.53
Current Price $53.57
Current
$53.57
Target
$36.26
$26.65 $36.26 avg $40.53
Scenario Analysis
Bear Case
$26.65
-50.3%
Low target
Base Case
$36.26
-32.3%
Avg target
Bull Case
$40.53
+-24.3%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$56.50
-5.2% from high
52-Week Low
$34.08
+57.2% from low
50-Day SMA
$40.77
+31.4% vs SMA
200-Day SMA
$37.28
+43.7% vs SMA
RSI (14)
85.1
Overbought
Target vs 52W High
$36.26
-35.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 79% $1,330.33 +20.7%
RDY
Dr. Reddy's Laboratories
 Sell 44 50% — +0.0%
JNJ
Johnson & Johnson
 Buy 31 68% $299.55 +29.5%
MRK
Merck & Co. Inc.
 Buy 36 69% $159.27 +37.9%
PFE
Pfizer Inc.
 Hold 36 42% $33.90 +35.2%
BMY
Bristol-Myers Squibb Co
 Hold 36 39% $174.50 +219.0%
ZTS
Zoetis Inc
 Buy 24 58% $209.87 +176.5%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -32.3%